Dysphagia after stroke
Conditions
Interventions
the treatment group:swallowing training+Surface EMG biofeedback of suprhyoid muscle group
the control group:swallowing training
Sponsors
The Second Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for the treatment group: 1. Patients with cerebral infarction or cerebral hemorrhage that conform to the diagnostic criteria of the "Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke in China (2014)" and confirmed by CT or MRI; 2. First-time onset, aged 25-75 years; 3. Disease duration = 3 months; 4. Patients with dysphagia screened by the Water Swallowing Test scale in the "Chinese Expert Consensus on Dysphagia Assessment and Treatment (2017)" (Kubota Water Swallowing Test Grade III-V), without other related diseases causing dysphagia; 5. Able to understand and execute simple instructions from the treatment personnel, able to sit upright independently or with assistance for 30 minutes, and cooperate to complete treatment and assessment; 6. Stable vital signs and clear consciousness; 7. The subjects fully understand the purpose, methods, risks, and benefits of the study and sign the informed consent form. Inclusion criteria for the control group: 1. Subjects aged 25-75 years to ensure comparability with the treatment group; 2. Subjects must be in good health, without neurological diseases, muscular diseases, or other diseases that may affect swallowing function; 3. Subjects should not take medications that may affect brain electricity or muscle activity (such as sedatives, antidepressants, etc.) during the study period; 4. The total score of the Mini-Mental State Examination (MMSE) is within the normal range, and subjects can understand and execute instructions from the treatment personnel; 5. Subjects fully understand the purpose, methods, risks, and benefits of the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Patients with more than one stroke; 2. Patients with other diseases that affect swallowing function, such as myasthenia gravis, craniocerebral injury, head and neck tumors, etc.; 3. Patients with severe aphasia, psychiatric symptoms, etc. that affect treatment; 4. Patients with severe cardiopulmonary dysfunction, liver and kidney dysfunction, unstable arrhythmias, malignant tumors, malignant progressive hypertension, etc. that affect the treatment process; 5. Patients with organic dysphagia; 6. Patients with cardiac pacemakers, metal implants, or orthotics; 7. Patients with skin lesions on the head and neck or allergies to electrode patches.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surface electromyography ;EEG nonlinear dynamics analysis.; | — |
Secondary
| Measure | Time frame |
|---|---|
| functional oral intake scale;modified Mann assessment of swallowing ability;swallow severity scale;SWAL-QOL; | — |
Countries
China
Contacts
Public ContactHuifang Cao
The Second Hospital of Hebei Medical University
Outcome results
None listed